SCHEMBL1471723

SCHEMBL1471723

C(OCC1CO1)C1CO1.CC(CO)(CO)CO

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.57
MAPK1 P28482 1/20 0.57
ALDH1A1 P00352 8/20 0.50
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 4/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP1A2 P05177 1/20 0.38
PPARG P37231 1/20 0.38
CYP3A4 P08684 2/20 0.33
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4461926 0.89 TSHR (0.59) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL1471724 0.88 TSHR (0.64) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL17965675 0.88 TSHR (0.64) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL7725829 0.87 TSHR (0.63) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL50007 0.87 TSHR (0.63) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL27937976 0.85 ALDH1A1 (0.50) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
Methacrylic Acid SCHEMBL27476394 0.85 ALDH1A1 (0.50) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
Propane SCHEMBL3297482 0.84 TSHR (0.60) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL27877270 0.84 TSHR (0.64) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1
SCHEMBL1908201 0.84 TSHR (0.70) TSHRMAPK1ALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240091150-A1 PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2024-03-21 US claimed
CN-116601208-A Pharmaceutical composition comprising a composition having thickening properties of a polar medium as a thickening agent 化工产品开发公司SEPPIC 2023-08-15 CN claimed
CN-114231185-B Seam beautifying agent capable of rapidly curing system and preparation method and application thereof 武汉市科达云石护理材料有限公司 2023-06-02 CN claimed
CN-114231185-A Seam beautifying agent capable of quickly curing system and preparation method and application thereof 武汉市科达云石护理材料有限公司 2022-03-25 CN claimed
CN-114173560-A Article comprising crosslinked guanidino-containing polymers and uses thereof 3M创新有限公司 2022-03-11 CN claimed
CN-108602952-A Novel polyamines, a process for their synthesis and their use for the selective removal of H2S from gaseous effluents containing CO2 IFP 新能源公司 2018-09-28 CN claimed
CN-104829809-A High-molecular foam material ZUWEN WANG 2015-08-12 CN claimed
US-7913857-B2 Polyamide overcoated with a crosslinked epoxy resin and a hydrophilic compound, being covalently bonded to the polyamide membrane; reverse osmosis membrane; water insolubility; permselectivity WOONGJIN CHEMICAL CO., LTD. (KR) 2011-03-29 US claimed
EP-2140929-A1 Selective membrane having a high fouling resistance and preparation method thereof Woongjin Chemical Co., Ltd. (KR) 2010-01-06 EP claimed
US-20070175821-A1 Selective membrane having a high fouling resistance TORAY ADVANCED MATERIALS KOREA INC, (KR) 2007-08-02 US claimed
US-20030121844-A1 Selective membrane having a high fouling resistance SAEHAN INDUSTRIES INCORPORATION (KR) 2003-07-03 US claimed
CN-114173560-B Articles comprising crosslinked guanidine-containing polymers and uses thereof 舒万诺知识产权公司 2024-07-09 CN disclosed
CN-117757222-A Epoxy resin composition and application thereof 万华化学集团电子材料有限公司 2024-03-26 CN disclosed
US-20240091150-A1 PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2024-03-21 US disclosed
US-20240091109-A1 COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2024-03-21 US disclosed
EP-2140929-A1 Selective membrane having a high fouling resistance and preparation method thereof Woongjin Chemical Co., Ltd. (KR) 2010-01-06 EP disclosed
US-20070175821-A1 Selective membrane having a high fouling resistance TORAY ADVANCED MATERIALS KOREA INC, (KR) 2007-08-02 US disclosed
CN-1894299-A Solvent-free urethane composition CELUSTER PAINT CO LTD (JP) 2007-01-10 CN disclosed
US-6913694-B2 Selective membrane having a high fouling resistance SAEHAN INDUSTRIES INCORPORATION (KR) 2005-07-05 US disclosed
US-20030121844-A1 Selective membrane having a high fouling resistance SAEHAN INDUSTRIES INCORPORATION (KR) 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240091109-A1 COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA PHOSPHO1, GRIA1, GRM7 TSHR 4235/4885MAPK1 3147/4885ALDH1A1 3020/4885
US-20240091150-A1 PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES PHOSPHO1, GYPA, SGTA TSHR 3497/4885MAPK1 3113/4885ALDH1A1 3432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.